Understanding Immune Cells to Prevent Organ Transplant Rejection
Control of dysfunctional Tregs
This research aims to understand how certain immune cells, called Tregs, work to prevent organ transplant rejection and autoimmune diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11015884 on NIH RePORTER |
What this research studies
Organ transplant rejection is a significant challenge for patients, and this research looks into the basic ways our immune system's T regulatory cells (Tregs) can become dysfunctional. We are exploring how a specific protein, DHX15, helps these Tregs maintain their identity and survive, which is crucial for them to do their job. By understanding how DHX15 controls Tregs, we hope to find new ways to help transplanted organs last longer and prevent the immune system from attacking the body in autoimmune conditions. This work could lead to better treatments for people who have received organ transplants or suffer from autoimmune disorders.
Who could benefit from this research
Good fit: This foundational research is for patients interested in the underlying causes of organ transplant rejection and autoimmune conditions.
Not a fit: Patients seeking immediate treatment options or direct clinical intervention would not directly benefit from this early-stage laboratory research.
Why it matters
Potential benefit: If successful, this work could lead to new therapies that improve the long-term success of organ transplants and offer new ways to treat autoimmune diseases.
How similar studies have performed: This research builds upon previous findings by the same team regarding Treg dysfunction and the role of specific proteins, suggesting a progressive and novel line of inquiry.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Li, Xian Chang — Methodist Hospital Research Institute
- Study coordinator: Li, Xian Chang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.